Skip to main content
SpringerLink
Log in

Complications Post-TAVI

  • Chapter
  • First Online:
Percutaneous Treatment of Left Side Cardiac Valves

  • 1062 Accesses

Abstract

Transcatheter aortic valve replacement (TAVR) has become the standard of care for inoperable patients with symptomatic severe aortic stenosis [1] and a good alternative to surgical aortic valve replacement for patients at high surgical risk [2]. Worldwide, two types of transcatheter heart valves (THVs) have been most used to date: the balloon-expandable Edwards valve (Cribier-Edwards, Edwards SAPIEN, SAPIEN XT, and SAPIEN 3; Edwards Lifesciences, Irvine, CA) and the self-expandable CoreValve system (CoreValve, Evolut, Evolut R; Medtronic, Minneapolis, MN). In the past few years, other transcatheter valves have also received CE mark approval and are now commonly used (e.g., Direct Flow, Lotus Valve, Portico, JenaValve, Symetis). Despite significant progress in the technology of transcatheter valves over the last decade, several complications remain associated with this less-invasive procedure. This chapter seeks to review the major significant complications following TAVR. Methods of prevention and treatment of those hurdles will also be appraised.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  CAS  PubMed  Google Scholar 

  2. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    Article  CAS  PubMed  Google Scholar 

  3. Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696–704.

    Article  CAS  PubMed  Google Scholar 

  4. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.

    Article  CAS  PubMed  Google Scholar 

  5. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425–33.

    Article  PubMed  Google Scholar 

  6. Gilard M, Eltchaninoff H, Iung B, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15.

    Article  CAS  PubMed  Google Scholar 

  7. Rodes-Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864–75.

    Article  PubMed  Google Scholar 

  8. Hamm CW, Mollmann H, Holzhey D, et al. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98.

    Article  PubMed  Google Scholar 

  9. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011;58:2130–8.

    Article  PubMed  Google Scholar 

  10. Chieffo A, Buchanan GL, Van Mieghem NM, et al. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). J Am Coll Cardiol. 2013;61:830–6.

    Article  PubMed  Google Scholar 

  11. Di Mario C, Eltchaninoff H, Moat N, et al. The 2011–12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4571 patients. EuroIntervention. 2013;8:1362–71.

    Article  PubMed  Google Scholar 

  12. Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310:2069–77.

    Article  CAS  PubMed  Google Scholar 

  13. Linke A, Wenaweser P, Gerckens U, et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur Heart J. 2014;35(38):2672–84. doi:10.1093/eurheartj/ehu162.

    Article  PubMed  Google Scholar 

  14. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–14.

    Article  PubMed  CAS  Google Scholar 

  15. Takagi H, Umemoto T, for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival. Int J Cardiol. 2016;221:46–51.

    Article  PubMed  Google Scholar 

  16. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438–54.

    Article  PubMed  Google Scholar 

  17. Lerakis S, Hayek SS, Douglas PS. Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge. Circulation. 2013;127:397–407.

    Article  PubMed  Google Scholar 

  18. Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585–9.

    Article  PubMed  Google Scholar 

  19. Nombela-Franco L, Ruel M, Radhakrishnan S, et al. Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol. 2013;111(7):1026–33.

    Article  PubMed  Google Scholar 

  20. Popma J, Adams D, Reardon M, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–81.

    Article  PubMed  Google Scholar 

  21. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.

    Article  CAS  PubMed  Google Scholar 

  22. Reardon MJ, Adams DH, Kleiman NS, et al. 2-Year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol. 2015;66:113–21.

    Article  PubMed  Google Scholar 

  23. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299–308.

    Article  PubMed  Google Scholar 

  24. van Belle E, Juthier F, Susen S, et al. Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry. Circulation. 2014;129:1415–27.

    Article  PubMed  Google Scholar 

  25. Miyazaki S, Agricola E, Panoulas VF, et al. Influence of baseline ejection fraction on the prognostic value of paravalvular leak after transcatheter aortic valve implantation. Int J Cardiol. 2015;190:277–81.

    Article  PubMed  Google Scholar 

  26. Mack MJ, Leon MB, Smith CR, et al. 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;1:8.

    Google Scholar 

  27. Jerez-Valero M, Urena M, Webb JG, et al. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation. JACC Cardiovasc Interv. 2014;7:1022–32.

    Article  PubMed  Google Scholar 

  28. Koos R, Mahnken AH, Dohmen G, et al. Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol. 2011;150:142–5.

    Article  PubMed  Google Scholar 

  29. Colli A, D’Amico R, Kempfert J, et al. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp calcification on postoperative aortic regurgitation. J Thorac Cardiovasc Surg. 2011;142:1229–35.

    Article  PubMed  Google Scholar 

  30. Yared K, Garcia-Camarero T, Fernandez-Friera L, et al. Impact of aortic regurgitation after transcatheter aortic valve implantation: results from the REVIVAL trial. JACC Cardiovasc Imaging. 2012;5:469–77.

    Article  PubMed  Google Scholar 

  31. Détaint D, Lepage L, Himbert D, et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv. 2009;2:821–7.

    Article  PubMed  Google Scholar 

  32. Schultz CJ, Tzikas A, Moelker A, et al. Correlates on MSCT of paravalvular aortic regurgitation after transcatheter aortic valve implantation using the Medtronic CoreValve prosthesis. Catheter Cardiovasc Interv. 2011;78:446–55.

    Article  PubMed  Google Scholar 

  33. Généreux P, Head SJ, Hahn R, et al. Paravalvular leak after transcatheter aorticvalve replacement: the new Achilles’ heel? A comprehensive review of the literature. J Am Coll Cardiol. 2013;61:1125–36.

    Article  PubMed  Google Scholar 

  34. Van Belle E, Rauch A, Vincent F, et al. Von Willebrand factor multimers during transcatheter aortic-valve replacement. N Engl J Med. 2016;375(4):335–44. doi:10.1056/NEJMoa1505643.

    Article  PubMed  CAS  Google Scholar 

  35. Willson AB, Webb JG, Labounty TM, et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol. 2012;59:1287–94.

    Article  PubMed  Google Scholar 

  36. Mylotte D, Dorfmeister M, Elhmidi Y, et al. Erroneous measurement of the aortic annular diameter using 2-dimensional echocardiography resulting in inappropriate CoreValve size selection: a retrospective comparison with multislice computed tomography. JACC Cardiovasc Interv. 2014;7:652–61.

    Article  PubMed  Google Scholar 

  37. Jilaihawi H, Doctor N, et al. Aortic annular sizing for transcatheteraortic valve replacement using cross-sectional 3-dimensional transesophageal echocardiography. J Am Coll Cardiol. 2013;61:908–16.

    Article  PubMed  Google Scholar 

  38. Khalique OK, Kodali SK, Paradis JM, et al. Aortic annular sizing using a novel 3-dimensional echocardiographic method use and comparison with cardiac computed tomography. Circ Cardiovasc Imaging. 2014;7:155–63.

    Article  PubMed  Google Scholar 

  39. Sinning JM, Werner N, Nickenig G, Grube E. Challenges in transcatheter valve treatment: aortic regurgitation after transcatheter aortic valve implantation. EuroIntervention. 2013;9(Suppl):S72–6.

    Article  PubMed  Google Scholar 

  40. Nombela-Franco L, Rodes-Cabau J, DeLarochelliere R, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5:499–512.

    Google Scholar 

  41. Makkar RR, Jilaihawi H, Chakravarty T, et al. Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). J Am Coll Cardiol. 2013;62:418–30.

    Article  PubMed  Google Scholar 

  42. Saia F, Martinez C, Gafoor S, et al. Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience. JACC Cardiovasc Interv. 2015;8:681–8.

    Article  PubMed  Google Scholar 

  43. Herrmann HC, Thourani VH, Kodali SK, et al. One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation. 2016;134(2):130–40. doi:10.1161/CIRCULATIONAHA.116.022797.

    Article  PubMed  Google Scholar 

  44. Manoharan G, Walton AS, Brecker SJ, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8(10):1359–67.

    Article  PubMed  Google Scholar 

  45. Meredith IT, Walters DL, Dumonteil N, et al. 1-Year outcomes with the fully repositionable and retrievable lotus transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: results of the REPRISE II study. JACC Cardiovasc Interv. 2016;9(4):376–84.

    Article  PubMed  Google Scholar 

  46. Schofer J, Colombo A, Klugmann S, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol. 2014;63(8):763–8.

    Article  PubMed  Google Scholar 

  47. Manoharan G, Linke A, Möllmann H, et al. Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system. EuroIntervention. 2016;12:768–74.

    Article  PubMed  Google Scholar 

  48. Silaschi M, Treede H, Rastan AJ, et al. The JUPITER registry: 1-year results of transapical aortic valve implantation using a second-generation transcatheter heart valve in patients with aortic stenosis. Eur J Cardiothorac Surg. 2016;50(5):874–81.

    Article  PubMed  Google Scholar 

  49. Kempfert J, Holzhey D, Hofmann S, et al. First registry results from the newly approved ACURATE TA™ TAVI system. Eur J Cardiothorac Surg. 2015;48(1):137–41.

    Article  PubMed  Google Scholar 

  50. Webb J, Gerosa G, Lefèvre T, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64:2235–43. doi:10.1016/j. jacc.2014.09.026.

    Article  PubMed  Google Scholar 

  51. Herrmann HC. New transcatheter aortic valve prosthesis sets a new standard. J Am Coll Cardiol. 2014;64:2244–5. doi:10.1016/j.jacc.2014.08.042.

    Article  PubMed  Google Scholar 

  52. Ando T, Briasoulis A, Holmes AA, Taub CC, Takagi H, Afonso L. Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: a meta-analysis. Int J Cardiol. 2016;220:472–8. doi:10.1016/j.ijcard.2016.06.159.

    Article  PubMed  Google Scholar 

  53. Lefèvre T, Colombo A, Tchétché D, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve system: 12-month outcomes of the evaluation of the direct flow medical percutaneous aortic valve 18F system for the treatment of patients with severe aortic stenosis (DISCOVER) study. JACC Cardiovasc Interv. 2016;9(1):68–75.

    Article  PubMed  Google Scholar 

  54. Sondergaard L, Worthley S, Rodes J, Maisano F. Safety and performance of the Portico valve in patients with severe aortic stenosis and excessive surgical risk: a first report of 30-day results from the PORTICO I study. Published in Abstracts EuroPCR 2016, May 2016.

    Google Scholar 

  55. Bax JJ, Delgado V, Bapat V, et al. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation. Eur Heart J. 2014;35:2639–54.

    Article  PubMed  Google Scholar 

  56. Siontis GC, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64:129–40.

    Article  PubMed  Google Scholar 

  57. Carrabba N, Valenti R, Migliorini A, et al. Impact on left ventricular function and remodeling and on 1-year outcome in patients with left bundle branch block after transcatheter aortic valve implantation. Am J Cardiol. 2015;116:125–31.

    Article  PubMed  Google Scholar 

  58. Schymik G, Tzamalis P, Bramlage P, et al. Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort. Clin Res Cardiol. 2015;104:351–62.

    Article  PubMed  Google Scholar 

  59. Urena M, Webb JG, Cheema A, et al. Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2014;7:128–36.

    Article  PubMed  Google Scholar 

  60. Houthuizen P, van der Boon RM, Urena M, et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention. 2014;9:1142–50.

    Article  PubMed  Google Scholar 

  61. Nazif TM, Williams MR, Hahn RT, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2014;35:1599–607.

    Article  PubMed  Google Scholar 

  62. Franzoni I, Latib A, Maisano F, et al. Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol. 2013;112:554–9.

    Article  PubMed  Google Scholar 

  63. Testa L, Latib A, De Marco F, et al. Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System. Circulation. 2013;127:1300–7.

    Article  PubMed  Google Scholar 

  64. Van der Boon RM, Nuis RJ, Van Mieghem NM, et al. New conduction abnormalities after TAVI—frequency and causes. Nat Rev Cardiol. 2012;9:454–63.

    Article  PubMed  Google Scholar 

  65. Petronio AS, Sinning JM, Van Mieghem N, et al. Optimal implantation depth and adherence to guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the Medtronic CoreValve system: the CoreValve prospective, international, post-Market ADVANCE-II Study. JACC Cardiovasc Interv. 2015;8:837–46.

    Article  PubMed  Google Scholar 

  66. Urena M, Rodés-Cabau J. Managing heart block after transcatheter aortic valve implantation: from monitoring to device selection and pacemaker indications. EuroIntervention. 2015;11(suppl W):W101–5. doi:10.4244/EIJV11SWA30.

    Article  PubMed  Google Scholar 

  67. Tarantini G, Mojoli M, Purita P, Napodano M, D’Onofrio A, Frigo A, Covolo E, Facchin M, Isabella G, Gerosa G, Iliceto S. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. EuroIntervention. 2015;11:343–50. doi:10.4244/EIJY14M11_06.

    Article  PubMed  Google Scholar 

  68. Toggweiler S, Stortecky S, Holy E, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016;9(12):1269–76.

    Article  PubMed  Google Scholar 

  69. Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, et al. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9(5):e003635.

    Article  PubMed  Google Scholar 

  70. Genereux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317–26.

    Article  PubMed  Google Scholar 

  71. Genereux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012;60:1043–52.

    Article  PubMed  Google Scholar 

  72. Khatri PJ, Webb JG, Rodes-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Internal Med. 2013;158:35–46.

    Article  Google Scholar 

  73. Panchal HB, Ladia V, Amin P, et al. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis. Am J Cardiol. 2014;114(12):1882–90.

    Article  PubMed  Google Scholar 

  74. Steinvil A, Leshem-Rubinow E, et al. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions. Am J Cardiol. 2015;115(1):100–6.

    Article  PubMed  Google Scholar 

  75. Genereux P, Head SJ, Wood DA, et al. Transcatheter aortic valve implantation: 10-year anniversary. Part II: clinical implications. Eur Heart J. 2012;33:2399–402.

    Article  PubMed  Google Scholar 

  76. Hayashida K, Lefèvre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4:851–8.

    Article  PubMed  Google Scholar 

  77. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. J Am Coll Cardiol. 2012;59:113–8.

    Article  PubMed  Google Scholar 

  78. Van Mieghem NM, Tchetche D, Chieffo A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2012;110:1361–7.

    Article  PubMed  Google Scholar 

  79. Barbash IM, Barbanti M, Webb J, et al. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Eur Heart J. 2015;36(47):3370–9.

    Article  PubMed  Google Scholar 

  80. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.

    Article  CAS  PubMed  Google Scholar 

  81. Holmes DR, Brennan JM, Rumsfeld JS, et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313:1019–28.

    Article  CAS  PubMed  Google Scholar 

  82. Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol. 2015;65:2173–80.

    Article  PubMed  Google Scholar 

  83. Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129–38.

    Article  PubMed  Google Scholar 

  84. Auffret V, Regueiro A, Del Trigo M, et al. Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;68(7):673–84.

    Article  PubMed  Google Scholar 

  85. Bendszus M, Stoll G. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol. 2006;5:364–72.

    Article  PubMed  Google Scholar 

  86. Fairbairn TA, Mather AN, Bijsterveld P, Worthy G, Currie S, Goddard AJ, Blackman DJ, Plein S, Greenwood JP. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012;98:18–23.

    Article  PubMed  Google Scholar 

  87. Rodes-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bedard F, Doyle D, De Larochelliere R, Jayasuria C, Villeneuve J, Marrero A, Cote M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18–28.

    Article  PubMed  Google Scholar 

  88. Drews T, Pasic M, Buz S, et al. Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg. 2011;59:237–42.

    Article  CAS  PubMed  Google Scholar 

  89. Miller DC, Blackstone EH, Mack MJ, et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg. 2012;143:832–843.e13.

    Article  PubMed  Google Scholar 

  90. Athappan G, Gajulapalli RD, Sengodan P, et al. Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. J Am Coll Cardiol. 2014;63:2101–10.

    Article  PubMed  Google Scholar 

  91. Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126:3041–53.

    Article  PubMed  Google Scholar 

  92. Freeman M, Barbanti M, Wood DA, et al. Cerebral events and protection during transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2014;84:885–96.

    Article  PubMed  Google Scholar 

  93. Rodes-Cabau J, Kahlert P, Neumann F-J, et al. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. JACC Cardiovasc Interv. 2014;7:1146–55.

    Article  PubMed  Google Scholar 

  94. Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015;36:2070–8.

    Article  PubMed  Google Scholar 

  95. Van Mieghem NM, Schipper MEI, Ladich E, et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation. 2013;127:2194–201.

    Article  PubMed  Google Scholar 

  96. Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013;62:1552–62.

    Article  PubMed  Google Scholar 

  97. Généreux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317–26.

    Article  PubMed  Google Scholar 

  98. Barbanti M, Yang T-H, Rodes-Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128:244–53.

    Article  PubMed  Google Scholar 

  99. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, D’Ancona G, Seifert B, Hetzer R. Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication. Circ Cardiovasc Interv. 2012;5:424–32.

    Article  PubMed  Google Scholar 

  100. Rezq A, Basavarajaiah S, Latib A, et al. Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a single-center study. JACC Cardiovasc Intervent. 2012;5:1264–72.

    Article  Google Scholar 

  101. Córdoba-Soriano JG, Puri R, Amat-Santos I, et al. Valve thrombosis following transcatheter aortic valve implantation: a systematic review. Rev Esp Cardiol (Engl Ed). 2015;68(3):198–204.

    Article  Google Scholar 

  102. Latib A, Naganuma T, Abdel-Wahab M, et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv. 2015;8.

    Google Scholar 

  103. Del Trigo M, Muñoz-Garcia AJ, Wijeysundera HC, et al. Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol. 2016;67:644–55.

    Article  PubMed  Google Scholar 

  104. Leetmaa T, Hansson NC, Leipsic J, et al. Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv. 2015;8.

    Google Scholar 

  105. Pache G, Schoechlin S, Blanke P, et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J. 2016;37(28):2263–71.

    Article  PubMed  Google Scholar 

  106. Hansson NC, Grove EL, Andersen HR, et al. Transcatheter aortic heart valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol. 2016;68(19):2059–69. pii: S0735-1097(16)34936-1

    Article  PubMed  Google Scholar 

  107. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for CardioThoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg. 2012;144:e29–84.

    Article  PubMed  Google Scholar 

  108. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1–S44.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada

    Chekrallah Chamandi M.D. & Josep Rodés-Cabau M.D.

Authors
  1. Chekrallah Chamandi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josep Rodés-Cabau M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josep Rodés-Cabau M.D. .

Editor information

Editors and Affiliations

  1. Ferrarotto Hospital, University of Catania, Catania, Italy

    Corrado Tamburino

  2. Ferrarotto Hospital, University of Catania, Catania, Italy

    Marco Barbanti

  3. Ferrarotto Hospital, University of Catania, Catania, Italy

    Davide Capodanno

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Chamandi, C., Rodés-Cabau, J. (2018). Complications Post-TAVI. In: Tamburino, C., Barbanti, M., Capodanno, D. (eds) Percutaneous Treatment of Left Side Cardiac Valves. Springer, Cham. https://doi.org/10.1007/978-3-319-59620-4_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59620-4_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59619-8

  • Online ISBN: 978-3-319-59620-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation